Professor Mark Schembri
Professor

Mark Schembri

Email: 
Phone: 
+61 7 336 53306

Background

Professor Mark Schembri is a prominent microbiologist with experience in combating the global health crisis presented by multi-drug resistant pathogens. Professor Schembri’s expertise on the virulence of bacterial pathogens and his innovative analysis of biofilm formation aims to improve the outcomes of the >400 million individuals that suffer from urinary tract infections each year across the globe.

Through the application of genetic, genomic and functional studies on uropathogenic E. coli, Professor Schembri has identified targets to reduce the virulence of this pathogen, and will pursue the development of life-saving therapeutic and preventative advances with the assistance of NHMRC, MRFF and ARC grants. Professor Schembri has tracked the rapid emergence and global spread of a virulent, drug-resistant E. coli clone and used genome sequencing to understand its evolution and virulence.

Links: Professor Schembri collaborates with national and international research leaders, including in Denmark, where he was a lecturer. Professor Schembri has strong links with other international experts in his field, including at the Pasteur Institute and the Wellcome Trust Sanger Institute in Cambridge. His research collaborations also span lead groups at UQ and other top Australian institutes, including Griffith and La Trobe Universities.

Membership, Funding and patents: Since 2014, Professor Schembri has been awarded over $15 million in funding from competitive national research funding bodies. He holds provisional patents for the development of novel therapeutic agents and vaccine antigens. He is a Fellow of the American Academy of Microbiology, and is regularly invited to speak at international conferences in his field.

Awards and Communication: Professor Schembri was the recipient of the Frank Fenner Award (2010) and the ASM BacPath Oration Award (2019) for his outstanding original research contribution to the study of Infectious Disease. He was an Australian Research Council Future Fellow (2011-2015) a National Health and Medical Research Council Senior Research Fellow (2016-2020). Professor Schembri is the author of >240 peer-reviewed research manuscripts. He is President of the Australian Society for Microbiology (2022-2026).

Availability

Professor Mark Schembri is:
Available for supervision

Fields of research

Medical microbiology Microbiology

Qualifications

  • Doctor of Philosophy, Monash University

Research impacts

Professor Schembri’s outstanding original work in the field of infectious disease and multi-drug resistant pathogens has led to several key advances in the fight to reduce the prevalence and improve outcomes of urinary tract infections.

Key research outputs: The genomic epidemiology of the most widespread antibiotic resistant uropathogenic E. coli clone allowed its origin and dissemination to be mapped on a global scale. Recent work in Professor Schembri’s group has defined the virulence of this pathogen using advanced genetic, transcriptomic and proteomic methods in conjunction with mouse models of infection. He has also led the use of new treatments to prevent infection by this antibiotic resistant pathogen.

Key capabilities: Professor Schembri has deep expertise in microbiology, with particular capability in the study of antibiotic resistant Gram-negative bacterial pathogens and high-throughput modelling of drug-resistant biofilms, as well as the application of forefront technologies to examine virulence, genomic epidemiology, host-pathogen interactions and novel strategies for the treatment/prevention of infectious diseases.

Search Professor Mark Schembri’s works on UQ eSpace

296 works between 1991 and 2025
All (296) Journal Article (268) Book Chapter (1) Conference Publication (21) Other Outputs (6)

21 - 40 of 296 works

2022

Journal Article

Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling

Manik, Mohammad K., Shi, Yun, Li, Sulin, Zaydman, Mark A., Damaraju, Neha, Eastman, Samuel, Smith, Thomas G., Gu, Weixi, Masic, Veronika, Mosaiab, Tamim, Weagley, James S., Hancock, Steven J., Vasquez, Eduardo, Hartley-Tassell, Lauren, Kargios, Nestoras, Maruta, Natsumi, Lim, Bryan Y. J., Burdett, Hayden, Landsberg, Michael J., Schembri, Mark A., Prokes, Ivan, Song, Lijiang, Grant, Murray, DiAntonio, Aaron, Nanson, Jeffrey D., Guo, Ming, Milbrandt, Jeffrey, Ve, Thomas and Kobe, Bostjan (2022). Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling. Science, 377 (6614) eadc8969, 1-11. doi: 10.1126/science.adc8969

Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling

2022

Journal Article

Enhancing the Thermal and Kinetic Stability of Ketol-Acid Reductoisomerase, a Central Catalyst of a Cell-Free Enzyme Cascade for the Manufacture of Platform Chemicals

Lv, You, Zheng, Shan, Goldenzweig, Adi, Liu, Fengjiang, Gao, Yan, Yang, Xiuna, Kandale, Ajit, McGeary, Ross P., Williams, Simon, Kobe, Bostjan, Schembri, Mark A., Landsberg, Michael J., Wu, Bin, Brück, Thomas B., Sieber, Volker, Boden, Mikael, Rao, Zihe, Fleishman, Sarel J., Schenk, Gerhard and Guddat, Luke W. (2022). Enhancing the Thermal and Kinetic Stability of Ketol-Acid Reductoisomerase, a Central Catalyst of a Cell-Free Enzyme Cascade for the Manufacture of Platform Chemicals. Applied Biosciences, 1 (2), 163-178. doi: 10.3390/applbiosci1020011

Enhancing the Thermal and Kinetic Stability of Ketol-Acid Reductoisomerase, a Central Catalyst of a Cell-Free Enzyme Cascade for the Manufacture of Platform Chemicals

2022

Journal Article

Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coli

Hancock, Steven J., Lo, Alvin W., Ve, Thomas, Day, Christopher J., Tan, Lendl, Mendez, Alejandra A., Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Peters, Kate M., Richards, Amanda C., Fleming, Brittany A., Chang, Chyden, Ngu, Dalton H. Y., Forde, Brian M., Haselhorst, Thomas, Goh, Kelvin G. K., Beatson, Scott A., Jennings, Michael P., Mulvey, Matthew A., Kobe, Bostjan and Schembri, Mark A. (2022). Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coli. PLoS Pathogens , 18 (6) e1010582, e1010582. doi: 10.1371/journal.ppat.1010582

Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coli

2022

Journal Article

Gut–bladder axis in recurrent UTI

Schembri, Mark A., Nhu, Nguyen Thi Khanh and Phan, Minh-Duy (2022). Gut–bladder axis in recurrent UTI. Nature Microbiology, 7 (5), 601-602. doi: 10.1038/s41564-022-01113-z

Gut–bladder axis in recurrent UTI

2022

Journal Article

Variation of Antigen 43 self-association modulates bacterial compacting within aggregates and biofilms

Vo, Julieanne L., Ortiz, Gabriela C. Martínez, Totsika, Makrina, Lo, Alvin W., Hancock, Steven J., Whitten, Andrew E., Hor, Lilian, Peters, Kate M., Ageorges, Valentin, Caccia, Nelly, Desvaux, Mickaël, Schembri, Mark A., Paxman, Jason J. and Heras, Begoña (2022). Variation of Antigen 43 self-association modulates bacterial compacting within aggregates and biofilms. npj Biofilms and Microbiomes, 8 (1) 20, 20. doi: 10.1038/s41522-022-00284-1

Variation of Antigen 43 self-association modulates bacterial compacting within aggregates and biofilms

2022

Journal Article

Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131

Phan, Minh-Duy, Peters, Kate M., Alvarez Fraga, Laura, Wallis, Steven C., Hancock, Steven, Nhu, Nguyen Thi Khanh, Forde, Brian, Bauer, Michelle J., Paterson, David L., Beatson, Scott A, Lipman, Jeffrey and Schembri, Mark A. (2022). Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131. Antimicrobial Agents and Chemotherapy, 66 (1) e02146-21, 1-11. doi: 10.1128/aac.02146-21

Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131

2022

Journal Article

Differential Afa/Dr fimbriae expression in the multidrug-resistant Escherichia coli ST131 clone

Alvarez-Fraga, Laura, Phan, Minh-Duy, Goh, Kelvin G. K., Nhu, Nguyen Thi Khanh, Hancock, Steven J., Allsopp, Luke P., Peters, Kate M., Forde, Brian M., Roberts, Leah W., Sullivan, Matthew J., Totsika, Makrina, Beatson, Scott A., Ulett, Glen C. and Schembri, Mark A. (2022). Differential Afa/Dr fimbriae expression in the multidrug-resistant Escherichia coli ST131 clone. mBio, 13 (1) e03519, e0351921. doi: 10.1128/mbio.03519-21

Differential Afa/Dr fimbriae expression in the multidrug-resistant Escherichia coli ST131 clone

2022

Journal Article

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

De Oliveira, David M. P., Forde, Brian M., Phan, Minh-Duy, Steiner, Bernhard, Zhang, Bing, Zuegg, Johannes, El-deeb, Ibrahim M., Li, Gen, Keller, Nadia, Brouwer, Stephan, Harbison-Price, Nichaela, Cork, Amanda J., Bauer, Michelle J., Alquethamy, Saleh F., Beatson, Scott A., Roberts, Jason A., Paterson, David L., McEwan, Alastair G., Blaskovich, Mark A. T., Schembri, Mark A., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2022). Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 13 (1) e03517, e0351721. doi: 10.1128/mbio.03517-21

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

2021

Journal Article

Modified horseshoe crab peptides target and kill bacteria inside host cells

Amiss, Anna S., von Pein, Jessica B., Webb, Jessica R., Condon, Nicholas D., Harvey, Peta J., Phan, Minh-Duy, Schembri, Mark A., Currie, Bart J., Sweet, Matthew J., Craik, David J., Kapetanovic, Ronan, Henriques, Sónia Troeira and Lawrence, Nicole (2021). Modified horseshoe crab peptides target and kill bacteria inside host cells. Cellular and Molecular Life Sciences, 79 (1) 38, 38. doi: 10.1007/s00018-021-04041-z

Modified horseshoe crab peptides target and kill bacteria inside host cells

2021

Journal Article

Short-term oral steroids significantly improves chronic rhinosinusitis without nasal polyps

De Silva, April P., Schembri, Mark A., Sarah, Angus H., Chao, Jessica, Yip, Kwok Ho, Cildir, Gökhan, Lopez, Angel, Tumes, Damon J. and Pant, Harshita (2021). Short-term oral steroids significantly improves chronic rhinosinusitis without nasal polyps. Laryngoscope, 131 (10), E2618-E2626. doi: 10.1002/lary.29495

Short-term oral steroids significantly improves chronic rhinosinusitis without nasal polyps

2021

Journal Article

Genome profiling of fluoroquinolone-resistant uropathogenic Escherichia coli isolates from Brazil

da Silva, Patrick, Lustri, Bruna C., Castilho, Ivana Giovannetti, Ferreira, Adriano Martison, Hernandes, Rodrigo T., Schembri, Mark A. and Moreira, Cristiano G. (2021). Genome profiling of fluoroquinolone-resistant uropathogenic Escherichia coli isolates from Brazil. Brazilian Journal of Microbiology, 52 (3), 1067-1075. doi: 10.1007/s42770-021-00513-3

Genome profiling of fluoroquinolone-resistant uropathogenic Escherichia coli isolates from Brazil

2021

Journal Article

Bacteriophage isolated from non‐target bacteria demonstrates broad host range infectivity against multidrug resistant bacteria

Ngiam, Lyman, Schembri, Mark A., Weynberg, Karen and Guo, Jianhua (2021). Bacteriophage isolated from non‐target bacteria demonstrates broad host range infectivity against multidrug resistant bacteria. Environmental Microbiology, 23 (9) 1462-2920.15714, 1-18. doi: 10.1111/1462-2920.15714

Bacteriophage isolated from non‐target bacteria demonstrates broad host range infectivity against multidrug resistant bacteria

2021

Journal Article

Characterisation of DtrJ as an IncC plasmid conjugative DNA transfer component

Hancock, Steven J., Phan, Minh‐Duy, Roberts, Leah, Vu, Thu Ngoc Minh, Harris, Patrick N.A., Beatson, Scott A. and Schembri, Mark A. (2021). Characterisation of DtrJ as an IncC plasmid conjugative DNA transfer component. Molecular Microbiology, 116 (1), 154-167. doi: 10.1111/mmi.14697

Characterisation of DtrJ as an IncC plasmid conjugative DNA transfer component

2021

Other Outputs

Modified defence peptides from horseshoe crab target and kill bacteria inside host cells

Amiss, Anna S., von Pein, Jessica B., Webb, Jessica R., Condon, Nicholas D., Harvey, Peta J., Phan, Minh-Duy, Schembri, Mark A., Currie, Bart J., Sweet, Matthew J., Craik, David J., Kapetanovic, Ronan, Henriques, Sónia Troeira and Lawrence, Nicole (2021). Modified defence peptides from horseshoe crab target and kill bacteria inside host cells. doi: 10.1101/2021.06.27.450110

Modified defence peptides from horseshoe crab target and kill bacteria inside host cells

2021

Journal Article

MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction

Murigneux, Valentine, Roberts, Leah W., Forde, Brian M., Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Irwin, Adam D., Harris, Patrick N. A., Paterson, David L., Schembri, Mark A., Whiley, David M. and Beatson, Scott A. (2021). MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction. BMC Genomics, 22 (1) 474, 474. doi: 10.1186/s12864-021-07767-z

MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction

2021

Journal Article

Discovery of bacterial fimbria–glycan interactions using whole-cell recombinant Escherichia coli expression

Day, Christopher J., Lo, Alvin W., Hartley-Tassell, Lauren E., Argente, M. Pilar, Poole, Jessica, King, Nathan P., Tiralongo, Joe, Jennings, Michael P. and Schembri, Mark A. (2021). Discovery of bacterial fimbria–glycan interactions using whole-cell recombinant Escherichia coli expression. mBio, 12 (1) e03664-20, 1-10. doi: 10.1128/mbio.03664-20

Discovery of bacterial fimbria–glycan interactions using whole-cell recombinant Escherichia coli expression

2021

Journal Article

Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care

Roberts, Leah W., Forde, Brian M., Hurst, Trish, Ling, Weiping, Nimmo, Graeme R., Bergh, Haakon, George, Narelle, Hajkowicz, Krispin, McNamara, John F., Lipman, Jeffrey, Permana, Budi, Schembri, Mark A., Paterson, David, Beatson, Scott A. and Harris, Patrick N. A. (2021). Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. Microbial Genomics, 7 (3) 000530. doi: 10.1099/mgen.0.000530

Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care

2021

Other Outputs

MicroPIPE: An end-to-end solution for high-quality complete bacterial genome construction

Murigneux, Valentine, Roberts, Leah W., Forde, Brian M., Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Irwin, Adam D., Harris, Patrick N. A., Paterson, David L., Schembri, Mark A., Whiley, David M. and Beatson, Scott A. (2021). MicroPIPE: An end-to-end solution for high-quality complete bacterial genome construction. doi: 10.1101/2021.02.02.429319

MicroPIPE: An end-to-end solution for high-quality complete bacterial genome construction

2021

Journal Article

An alloy of zinc and innate immunity: galvanizing host defence against infection

Pein, Jessica B., Stocks, Claudia J., Schembri, Mark A., Kapetanovic, Ronan and Sweet, Matthew J. (2021). An alloy of zinc and innate immunity: galvanizing host defence against infection. Cellular Microbiology, 23 (1) e13268, 1-11. doi: 10.1111/cmi.13268

An alloy of zinc and innate immunity: galvanizing host defence against infection

2020

Journal Article

Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

De Oliveira, David M. P., Bohlmann, Lisa, Conroy, Trent, Jen, Freda E.-C., Everest-Dass, Arun, Hansford, Karl A., Bolisetti, Raghu, El-Deeb, Ibrahim M., Forde, Brian M., Phan, Minh-Duy, Lacey, Jake A., Tan, Aimee, Rivera-Hernandez, Tania, Brouwer, Stephan, Keller, Nadia, Kidd, Timothy J., Cork, Amanda J., Bauer, Michelle J., Cook, Gregory M., Davies, Mark R., Beatson, Scott A., Paterson, David L., McEwan, Alastair G., Li, Jian, Schembri, Mark A., Blaskovich, Mark A. T., Jennings, Michael P., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2020). Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Science Translational Medicine, 12 (570) abb3791, eabb3791. doi: 10.1126/scitranslmed.abb3791

Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

Current funding

  • 2025 - 2026
    A Facility for Accelerated Microbial Phenotyping in Southeast Queensland
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2025 - 2027
    Molecular control of a bacterial fight or flight response
    ARC Discovery Projects
    Open grant
  • 2025 - 2029
    Global regulation of virulence and resistance in uropathogenic E. coli
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2028
    Unlocking the gut microbiome to track the spread of AMR genes and pathogens
    MRFF - Global Health Initiative
    Open grant
  • 2023 - 2026
    Untangling the matrix of bacterial biofilms
    ARC Discovery Projects
    Open grant
  • 2021 - 2025
    How a multidrug resistant bacterial pathogen has become pandemic
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2021 - 2024
    How bacteria form resistant aggregates and biofilms (ARC Discovery Project administered by La Trobe University).
    La Trobe University
    Open grant
  • 2020
    Rapid detection of resistance genes from Gram-negative bacteria isolated from blood in ICU-admitted patients
    Pathology Queensland - Study, Education & Research Trust Fund
    Open grant
  • 2020 - 2023
    Breaking antibiotic resistance in high priority Gram-negative sepsis pathogens
    NHMRC Development Grant
    Open grant
  • 2020 - 2023
    Understanding the role of specific virulence features in extra-intestinal E. coli clones
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Virulence and detection of Escherichia coli that cause neonatal meningitis
    The Children's Hospital Foundation
    Open grant
  • 2019
    A versatile accurate mass, high resolution QTOF mass spectrometer for chemistry and proteomic applications
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2023
    Cluster randomised trial of a multimodal intervention to reduce antimicrobial use in residential aged care facilities
    NHMRC MRFF - Antimicrobial Resistance Targeted Call for Research
    Open grant
  • 2018 - 2021
    How autotransporter proteins mediate bacterial interactions (ARC Discovery Project administered by La Trobe University)
    La Trobe University
    Open grant
  • 2018
    Epifluorescent and live-cell imaging microscopes for the investigation of host-pathogen interactions and for molecular and cellular biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
    NHMRC Project Grant
    Open grant
  • 2017 - 2018
    High-throughput technology targeting antimicrobial resistance in animals (ARC LIEF project administered by the University of Adelaide)
    University of Adelaide
    Open grant
  • 2017 - 2018
    Centre for Geoanalytical Mass Spectrometry (CGMS) - Achieving excellence in isotope geochemistry and geochronology
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2017 - 2020
    Epigenetic regulation in bacteria
    ARC Discovery Projects
    Open grant
  • 2017 - 2021
    Understanding Uropathogenic E. coli-mediated subversion of innate immunity
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Copper complexes as enhancers of antibiotic action against multi-drug resistant bacteria
    Queensland Emory Development Alliance
    Open grant
  • 2016 - 2018
    DsbA inhibitors: from hits to leads
    NHMRC Project Grant
    Open grant
  • 2016 - 2020
    Halting the spread multidrug resistant uropathogenic E. coli
    NHMRC Research Fellowship
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2019
    Membrane-active antibiotics against multi-drug resistant Gram negative bacteria
    NHMRC Project Grant
    Open grant
  • 2016
    Next-generation multi-collector inductively-coupled plasma mass spectrometer (MC-ICP-MS) with laser-ablation capability for in situ high-throughput and high resolution isotope dating and characterizat
    UQ Major Research Facility Fund
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    A sensitive, high resolution QTOF mass spectrometer with nanoUPLC system for qualitative and quantitative biomolecule analysis.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    A state-of-the-art spinning disc confocal microscope for high speed imaging of live cells and super resolution microscopy
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Addressing an unmet need by establishing a state-of-the-art translational model at UQ: The hollow fibre in vitro infection model
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Unraveling autotransporter function in bacterial aggregates and biofilms (ARC Discovery Project administered by La Trobe University)
    La Trobe University
    Open grant
  • 2014 - 2018
    Superbugs and veterinary drugs: Are multidrug-resistant zoonotic pathogens residing in Australian animals? (ARC Linkage Project administered by University of Adelaide)
    University of Adelaide
    Open grant
  • 2014 - 2016
    The current multidrug resistant Escherichia coli pandemic: exploring novel therapies against the predominant culprit E. coli ST131 (NHMRC project administered by QUT)
    Queensland University of Technology
    Open grant
  • 2014
    A confocal microscope for investigation of live bacterial and viral pathogens and for molecular cell biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014 - 2016
    A matter of life and death: defining novel interactions between uropathogenic E. coli and macrophages that influence UTI pathology
    NHMRC Project Grant
    Open grant
  • 2014
    Enrichment, detection and identification of bacteria in blood and urine.
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2014 - 2018
    Functional and genomic analysis of the globally disseminated multidrug resistant Escherichia coli ST131 clone
    NHMRC Project Grant
    Open grant
  • 2014
    The current multidrug resistant Escherichia coli pandemic: exploring novel therapies against the predominant culprit E. coli ST131.
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    Role of autotransporter proteins in uropathogenic E. coli infections
    NHMRC Project Grant
    Open grant
  • 2012 - 2013
    Overcoming membrane protein research roadblocks: A Queensland facility for membrane protein production and crystallisation
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2012 - 2013
    A high-throughput screening and sequencing facility for single cell genomics
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2012 - 2015
    Evolution and pathogenicity of NDM-1 positive Escherichia coli
    NHMRC Project Grant
    Open grant
  • 2012 - 2013
    Multi angle light scattering detector for the measurement of absolute molecular weight, size, and conformation of macromolecules in solution
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2015
    How Bacteria cause Disease in the Urinary Tract
    ARC Future Fellowships
    Open grant
  • 2011
    Cell culture facilities for studying host-pathogen interactions and immune function
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Escherichia coli ST131: an emerging pathogen
    NHMRC Project Grant
    Open grant
  • 2011
    Mass spectrometer for biomolecule discovery, structural analysis and quantification.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2014
    Role of macrophages in uropathogenic E. coli infections
    NHMRC Project Grant
    Open grant
  • 2010 - 2013
    Adhesins of uropathogenic Escherichia coli.
    NHMRC Project Grant
    Open grant
  • 2010
    An integrated high -throughput fluorescence imaging facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2012
    Autotransporter proteins of enterohemorrhagic E. coli O157:H7
    ARC Discovery Projects
    Open grant
  • 2010 - 2012
    Disulfide Catalysis and Protein Folding in Bacterial Virulence
    ARC Discovery Projects
    Open grant
  • 2010
    Establishment of a centralised live animal imaging fluorescence/bio-luminescence suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Metallo-beta-lactamases: predicting and combating antibiotic resistance.
    NHMRC Project Grant
    Open grant
  • 2009 - 2014
    E.coli cattle vaccine
    Queensland Government Smart State National and International Research Alliances Program
    Open grant
  • 2009 - 2011
    COMPARATIVE ANTI-BACTERIAL IMMUNITY IN THE URINARY TRACT: DOES ONE SIZE FIT ALL?
    NHMRC Project Grant
    Open grant
  • 2009
    Infrastructure for biochemistry and infectious disease resarch in molecualr biosciences
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2011
    Molecular basis of asymptomatic colonization of the human urinary tract
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Smart State Fellowship: New Approaches for the prevention of Biofilms caused by the 'Hospital Super-Bug', Staphylococcus aureus
    Queensland Government Smart State Fellowships
    Open grant
  • 2008
    Centriguge Facilities for dealing with live bacterial pathogens
    NHMRC Equipment Grant
    Open grant
  • 2007 - 2009
    Modelling streptococcal urogenital tract infection to study mechanisms of bacterial colonization and persistence
    NHMRC Project Grant
    Open grant
  • 2007 - 2009
    Molecular Characterization of E. coli that cause Urinary Tract Infection
    NHMRC Project Grant
    Open grant
  • 2006 - 2007
    A novel approach for the prevention of urinary tract infections
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2006 - 2009
    Effect of Co-infection of Porphyromonas gingivalis and Fusobacterium nucleatum in a Mouse Periodontitis
    Australian Dental Research Fund Inc
    Open grant
  • 2006 - 2008
    Safety in numbers: Bacterial aggregation and adaptation to oxidative stress
    ARC Discovery Projects
    Open grant
  • 2006 - 2008
    Urinary tract E. coli: The good guys versus the bad guys
    NHMRC Project Grant
    Open grant
  • 2005 - 2007
    Autotransporter proteins of Escherichia coli
    ARC Discovery Projects
    Open grant
  • 2005
    Molecular Characterisation of Urinary Tract Escherichia coli
    UQ Early Career Researcher
    Open grant
  • 2005
    NHMRC_Equipment Grant = Molecular Bacteriology Growth and Storage Facilities
    NHMRC Equipment Grant
    Open grant
  • 2005
    UQ TRAVEL AWARD CAT2-05
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2005
    The role of autotransporter proteins in adhesion and biofilm formation by Escherichia coli
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2004 - 2006
    Coordinate expression of virulence factors in pathogenic Escherichia coli
    NHMRC Project Grant
    Open grant
  • 2004
    Oxidative stress and autoaggregation in Escherichia coli
    UQ External Support Enabling Grant
    Open grant

Availability

Professor Mark Schembri is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    How bacteria form antibiotic resistant biofilms

    Principal Advisor

    Other advisors: Dr Nhu Nguyen, Dr Duy Phan

  • Doctor Philosophy

    Diversity, regulation and function of the uropathogenic Escherichia coli capsule

    Principal Advisor

    Other advisors: Professor Matt Sweet, Dr Duy Phan

  • Doctor Philosophy

    Understanding virulence factors and their regulation in uropathogenic Escherichia coli (UPEC)

    Principal Advisor

    Other advisors: Dr Nhu Nguyen

  • Doctor Philosophy

    Application of Transposon Directed Insertion Site Sequencing to Enhance Understanding of Essential Genes in Escherichia coli

    Associate Advisor

    Other advisors: Professor Ian Henderson

  • Doctor Philosophy

    Identifying new targets for treatment of antimicrobial resistant infections

    Associate Advisor

    Other advisors: Professor Ian Henderson

  • Doctor Philosophy

    Boosting innate immune defence to combat antibiotic-resistant bacterial infections

    Associate Advisor

    Other advisors: Dr Divya Ramnath, Professor Matt Sweet

  • Doctor Philosophy

    Application of Transposon Directed Insertion Site Sequencing to Enhance Understanding of Essential Genes in Escherichia coli

    Associate Advisor

    Other advisors: Professor Ian Henderson

  • Doctor Philosophy

    Genomic and molecular characterisation of antibiotic resistance mechanisms

    Associate Advisor

    Other advisors: Dr Brian Forde

  • Doctor Philosophy

    Microbial effects on host mitochondrial DNA

    Associate Advisor

    Other advisors: Associate Professor Steven Zuryn

Completed supervision

Enquiries

For media enquiries about Professor Mark Schembri's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au